Neurometrix Inc (NURO) Inventory Turnover Ratio, from fourth quarter 2024 to fourth quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Neurometrix Inc   (NASDAQ: NURO)
 

Neurometrix Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Neurometrix Inc 's inventory turnover ratio, the ratio that measures Neurometrix Inc 's ability to manage its supply chain, sequentially decreased to 0.95 in the fourth quarter 2024, which does not come as a surprise, as the Neurometrix Inc continue to experience headwinds, which also impact its supply chain. Neurometrix Inc 's average inventory processing period in the Dec 31 2024 quarter, has increased to 384 days, from 338 days, in the Sep 30 2024 quarter.

Within Healthcare sector 347 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1133 in the third quarter 2024, to 1741.

NURO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Neurometrix Inc Market Share?

What is Inventory Turnover Ratio?




NURO Inventory Turnover Ratio (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Inventory Growth -13.59 % -14.19 % -8.43 % -15.83 % -3.44 %
Y / Y Cost of Sales Growth -52.31 % -34.65 % -48.33 % 9.53 % -23.89 %
Inventory Turnover Ratio (TTM) 0.95 1.08 1.14 1.28 1.19
NURO's Total Ranking # 1741 # 1133 # 665 # 1178 # 969
Average inventory processing period 384 337 322 286 306
Seq. Inventory Growth -5.78 % -1.4 % -1.43 % -5.64 % -6.43 %
Seq. Cost of Sales Growth -18.63 % -0.68 % -51.91 % 22.73 % 11.48 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 152
Healthcare Sector # 348
Overall Market # 1741

Inventory Turnover Ratio Statistics
High Average Low
7.39 3.43 0.95
(Jun 30 2017)   (Dec 31 2024)




Financial Statements
Neurometrix Inc 's Inventories $ 1 Millions Visit NURO's Balance sheet
Neurometrix Inc 's Cost of Revenues TTM $ 1 Millions Visit NURO's Income Statement
What are NURO's Sales? Visit NURO's Sales by Segment

Other Inventory Turnover Ratios
Neurometrix Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NURO's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NURO's Competitors
Inventory Turnover Ratio for NURO's Suppliers
Inventory Turnover Ratio for NURO's Customers

You may also want to know
NURO's Sales Growth Rates NURO's Pe Price to earnings ratio NURO's Receivables Turnover Ratio NURO's Stock Quote
NURO's Net Income Growth Rates NURO's Ps Price to Sales ratio NURO's Sales per Employee NURO's Asset Turnover Ratio
NURO's Net Margin NURO's Pb Price to Book ratio NURO's Financial Strength Ratios NURO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2024 Inventories at quarter ending Dec 31 2024
Amphastar Pharmaceuticals Inc   2.74 $ 358.112  Millions$ 130  Millions
Orasure Technologies Inc  2.74 $ 106.000  Millions$ 39  Millions
Hologic Inc  2.72 $ 1,835.200  Millions$ 675  Millions
Lifevantage Corp  2.70 $ 42.000  Millions$ 16  Millions
Illumina Inc   2.67 $ 1,511.000  Millions$ 567  Millions
Dariohealth Corp   2.66 $ 13.000  Millions$ 5  Millions
Iridex Corp  2.64 $ 29.000  Millions$ 11  Millions
Revvity Inc  2.62 $ 1,041.749  Millions$ 397  Millions
Edap Tms Sa  2.62 $ 42.065  Millions$ 16  Millions
Quidelortho Corp  2.61 $ 1,496.400  Millions$ 574  Millions
Zynex inc   2.61 $ 39.429  Millions$ 15  Millions
Accelerate Diagnostics Inc   2.60 $ 8.000  Millions$ 3  Millions
Sunshine Biopharma Inc   2.60 $ 24.204  Millions$ 9  Millions
Aquestive Therapeutics Inc   2.57 $ 17.872  Millions$ 7  Millions
Immucell Corporation  2.56 $ 18.552  Millions$ 7  Millions
Tenon Medical Inc   2.55 $ 1.566  Millions$ 1  Millions
Perrigo Company Plc  2.54 $ 2,830.000  Millions$ 1,113  Millions
Sanuwave Health Inc   2.53 $ 8.084  Millions$ 3  Millions
Livanova Plc  2.47 $ 382.000  Millions$ 154  Millions
Inmed Pharmaceuticals Inc  2.46 $ 3.193  Millions$ 1  Millions
Mimedx Group Inc   2.46 $ 60.000  Millions$ 24  Millions
Encision Inc   2.43 $ 3.192  Millions$ 1  Millions
Tvardi Therapeutics Inc   2.43 $ 3.583  Millions$ 1  Millions
Neogen Corporation  2.41 $ 463.312  Millions$ 192  Millions
Merck and Co Inc   2.40 $ 15,193.000  Millions$ 6,333  Millions
Acadia Pharmaceuticals Inc   2.40 $ 81.841  Millions$ 34  Millions
Resmed Inc   2.38 $ 2,019.000  Millions$ 848  Millions
Urogen Pharma Ltd   2.37 $ 8.881  Millions$ 4  Millions
Sanara Medtech Inc   2.36 $ 8.000  Millions$ 3  Millions
Icu Medical Inc  2.35 $ 1,557.264  Millions$ 663  Millions

Date modified: 2026-09-08T15:11:28+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.